Abdominal wall complications following renal transplantation in adult recipients - factors associated with interventional management in one unit.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
21 Jan 2019
Historique:
received: 23 09 2018
accepted: 02 01 2019
entrez: 23 1 2019
pubmed: 23 1 2019
medline: 26 2 2019
Statut: epublish

Résumé

Abdominal wall surgical site complications following renal transplantation can be challenging to manage. A sub-group of these recipients will require operative management or advanced wound care such as negative pressure wound therapy (NPWT). The aim of this study was to determine if there were any preoperative, intraoperative and postoperative characteristics in our recipients' cohort which were associated with the requirement for such interventions. A retrospective review of medical records was performed for all recipients who sustained abdominal wall complications following renal transplantation at our centre from 2006 to 2016. A total of 64/828 recipients (7.7%) had abdominal wall complications. The mean weight for these patients was 84.9 kg (±16.6 kg) and the mean body mass index was 30.2 (±5.1). Forty-five recipients (70%) had a superficial wound dehiscence while nine (14%) had a complete fascial dehiscence. Operative intervention was required in 13/64 patients (20%) and was more likely to be required in the presence of a fascial dehiscence (9/9, 100%) or a wound collection (10/31, 32%) (p < 0.001, p = 0.021). NPWT was used in 17/64 patients (27%) and was more commonly required in patients with diabetes mellitus (10/24, 42%), a complete fascial dehiscence (5/9, 56%) or evidence of infection (16/44, 36%) (p = 0.039, p = 0.034, p = 0.008). The requirement for either operative management or the use of NPWT in the management of abdominal wall complications following renal transplantation in our experience was more common in recipients with diabetes mellitus, and in the setting of either complete fascial dehiscence, abdominal wall wound collections and/ or infection.

Sections du résumé

BACKGROUND BACKGROUND
Abdominal wall surgical site complications following renal transplantation can be challenging to manage. A sub-group of these recipients will require operative management or advanced wound care such as negative pressure wound therapy (NPWT). The aim of this study was to determine if there were any preoperative, intraoperative and postoperative characteristics in our recipients' cohort which were associated with the requirement for such interventions.
METHODS METHODS
A retrospective review of medical records was performed for all recipients who sustained abdominal wall complications following renal transplantation at our centre from 2006 to 2016.
RESULTS RESULTS
A total of 64/828 recipients (7.7%) had abdominal wall complications. The mean weight for these patients was 84.9 kg (±16.6 kg) and the mean body mass index was 30.2 (±5.1). Forty-five recipients (70%) had a superficial wound dehiscence while nine (14%) had a complete fascial dehiscence. Operative intervention was required in 13/64 patients (20%) and was more likely to be required in the presence of a fascial dehiscence (9/9, 100%) or a wound collection (10/31, 32%) (p < 0.001, p = 0.021). NPWT was used in 17/64 patients (27%) and was more commonly required in patients with diabetes mellitus (10/24, 42%), a complete fascial dehiscence (5/9, 56%) or evidence of infection (16/44, 36%) (p = 0.039, p = 0.034, p = 0.008).
CONCLUSIONS CONCLUSIONS
The requirement for either operative management or the use of NPWT in the management of abdominal wall complications following renal transplantation in our experience was more common in recipients with diabetes mellitus, and in the setting of either complete fascial dehiscence, abdominal wall wound collections and/ or infection.

Identifiants

pubmed: 30665387
doi: 10.1186/s12893-019-0468-x
pii: 10.1186/s12893-019-0468-x
pmc: PMC6341541
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Références

Eur J Surg. 2001 May;167(5):351-4; discussion 355
pubmed: 11419550
Transplantation. 2002 Sep 15;74(5):675-81
pubmed: 12352885
Clin Plast Surg. 2003 Jan;30(1):37-45
pubmed: 12636214
Transplantation. 2004 May 27;77(10):1555-61
pubmed: 15239621
Transplant Proc. 2005 Mar;37(2):717-20
pubmed: 15848512
Lancet. 2005 Nov 12;366(9498):1704-10
pubmed: 16291063
Transplant Proc. 2006 May;38(4):1044-6
pubmed: 16757258
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):127S-142S
pubmed: 16799380
Nephrol Dial Transplant. 2006 Oct;21(10):2908-15
pubmed: 16820375
Clin Transplant. 2006;20 Suppl 17:97-110
pubmed: 17100709
Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar;5(1):4-7
pubmed: 18603977
Transplant Proc. 2009 May;41(4):1221-3
pubmed: 19460523
Ann Surg. 2009 Dec;250(6):1014-20
pubmed: 19779327
Obes Rev. 2010 Dec;11(12):875-86
pubmed: 20025695
Am J Transplant. 2010 Oct;10(10):2370-3
pubmed: 20738265
Transplant Proc. 2010 Sep;42(7):2542-6
pubmed: 20832540
Am J Transplant. 2011 Feb;11(2):412
pubmed: 21219567
Int J Surg. 2011;9(5):378-81
pubmed: 21371577
J Surg Res. 2012 Apr;173(2):216-23
pubmed: 21816424
Hepatogastroenterology. 2011 May-Jun;58(107-108):738-9
pubmed: 21830380
Nephrology (Carlton). 2012 Aug;17(6):582-7
pubmed: 22624682
Transplant Proc. 2012 Jun;44(5):1275-80
pubmed: 22664000
Scand J Urol. 2013 Feb;47(1):63-71
pubmed: 22775432
Transplantation. 2012 Sep 27;94(6):547-61
pubmed: 22941182
Int J Surg. 2014;12(5):26-9
pubmed: 24246173
Curr Probl Surg. 2014 Jul;51(7):301-31
pubmed: 24935079
Case Rep Transplant. 2014;2014:742161
pubmed: 25374744
Prog Transplant. 2015 Mar;25(1):45-8
pubmed: 25758800
Infect Control Hosp Epidemiol. 2015 Apr;36(4):417-23
pubmed: 25782896
Coll Antropol. 2014 Dec;38(4):1199-201
pubmed: 25842757
BMC Med. 2015 May 12;13:111
pubmed: 25963131
Transplant Proc. 2015 Jun;47(5):1515-7
pubmed: 26093755
Int J Clin Pract. 2015 Nov;69(11):1357-65
pubmed: 26268780
World J Transplant. 2016 Dec 24;6(4):767-773
pubmed: 28058229
Clin Transplant. 2017 May;31(5):
pubmed: 28295629
Br J Surg. 1985 Oct;72(10):783-5
pubmed: 4041709

Auteurs

Ngee-Soon Lau (NS)

Department of Transplant Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. ngeesoon.lau@health.nsw.gov.au.

Nima Ahmadi (N)

Department of Transplant Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Deborah Verran (D)

Department of Transplant Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH